tiprankstipranks
Trending News
More News >
Neurogene (NGNE)
NASDAQ:NGNE
US Market

Compare Neurogene (NGNE) vs. Competitors

Compare
589 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Neurogene
$17.66
$273.55M
-3.99
13.72%
6 Buy
0 Hold
0 Sell
Strong Buy
Silence Therapeutics
$4.82
$227.67M
-2.88
-8.19%
2 Buy
0 Hold
0 Sell
Moderate Buy
Atea Pharmaceuticals
$4.24
$331.26M
-2.39
41.81%
2 Buy
0 Hold
0 Sell
Moderate Buy
Elicio Therapeutics
$7.60
$132.92M
-2.24
-19.32%
2 Buy
0 Hold
0 Sell
Moderate Buy
Vor Biopharma
$13.00
$284.84M
-0.03
-53.24%
6 Buy
1 Hold
0 Sell
Strong Buy
Tenaya Therapeutics
$1.33
$167.73M
-0.98
-26.98%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NGNE
Neurogene
17.66
0.82
4.87%
SLN
Silence Therapeutics
4.82
-0.24
-4.74%
AVIR
Atea Pharmaceuticals
4.24
1.32
45.21%
ELTX
Elicio Therapeutics
7.60
-1.32
-14.80%
VOR
Vor Biopharma
13.00
-13.80
-51.49%
TNYA
Tenaya Therapeutics
0.77
-0.28
-26.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts